XTX Topco Ltd acquired a new position in shares of CVRx, Inc. (NASDAQ:CVRX – Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 17,000 shares of the company’s stock, valued at approximately $150,000. XTX Topco Ltd owned about 0.07% of CVRx at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Rhumbline Advisers lifted its holdings in CVRx by 28.8% during the 2nd quarter. Rhumbline Advisers now owns 17,260 shares of the company’s stock worth $207,000 after buying an additional 3,863 shares during the last quarter. Jane Street Group LLC lifted its stake in CVRx by 36.1% during the third quarter. Jane Street Group LLC now owns 19,038 shares of the company’s stock worth $168,000 after purchasing an additional 5,053 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in CVRx by 30.7% in the second quarter. Bank of New York Mellon Corp now owns 37,191 shares of the company’s stock valued at $446,000 after purchasing an additional 8,741 shares in the last quarter. SG Americas Securities LLC acquired a new position in CVRx in the third quarter valued at approximately $108,000. Finally, Dimensional Fund Advisors LP purchased a new position in CVRx in the second quarter valued at approximately $218,000. Institutional investors and hedge funds own 75.27% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on CVRX. Piper Sandler restated an “overweight” rating and issued a $16.00 target price (up previously from $13.00) on shares of CVRx in a report on Wednesday, October 30th. Craig Hallum upped their price objective on shares of CVRx from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Lake Street Capital lifted their target price on CVRx from $12.00 to $15.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Canaccord Genuity Group upped their target price on CVRx from $17.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, December 9th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $14.00 price target on shares of CVRx in a research report on Wednesday, October 23rd. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, CVRx presently has an average rating of “Moderate Buy” and an average price target of $16.67.
CVRx Stock Performance
NASDAQ CVRX opened at $12.11 on Friday. The business’s 50-day moving average price is $13.07 and its 200 day moving average price is $10.59. The company has a quick ratio of 10.23, a current ratio of 11.32 and a debt-to-equity ratio of 0.76. The firm has a market cap of $293.84 million, a P/E ratio of -4.49 and a beta of 1.20. CVRx, Inc. has a 52-week low of $6.40 and a 52-week high of $33.13.
CVRx (NASDAQ:CVRX – Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.12). CVRx had a negative net margin of 123.75% and a negative return on equity of 89.06%. The company had revenue of $13.37 million during the quarter, compared to analyst estimates of $13.28 million. During the same period in the previous year, the firm posted ($0.43) EPS. On average, equities research analysts expect that CVRx, Inc. will post -2.62 earnings per share for the current year.
About CVRx
CVRx, Inc, a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure.
Featured Articles
- Five stocks we like better than CVRx
- How to Buy Cheap Stocks Step by Step
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Learn Technical Analysis Skills to Master the Stock Market
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 2 Underrated Quantum Computing Companies Starting to Rally
Want to see what other hedge funds are holding CVRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVRx, Inc. (NASDAQ:CVRX – Free Report).
Receive News & Ratings for CVRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVRx and related companies with MarketBeat.com's FREE daily email newsletter.